Literature DB >> 18194665

The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara.

Jian Yu1, Jianping Lan, Yuanyuan Zhu, Xiaoxiao Li, Xiaoyu Lai, Yu Xue, Changjiang Jin, He Huang.   

Abstract

Tara was identified as an interacting partner of guanine nucleotide exchange factor Trio and TRF1. Tara is proposed to be involved in many important fundamental cellular processes, ranging from actin remodeling, directed cell movement, to cell cycle regulation. Yet, its exact roles required further elucidation. Here, we identify a novel Tara-binding protein HECTD3, a putative member of HECT E3 ubiquitin ligases. HECTD3 directly binds Tara in vitro and forms a complex with Tara in vivo. Overexpression of HECTD3 enhances the ubiquitination of Tara in vivo and promotes the turnover of Tara, whereas depletion of HECTD3 by small interfering RNA decreases Tara degradation. Furthermore, depletion of HECTD3 leads to multipolar spindle formation. All these findings suggest that HECTD3 may facilitate cell cycle progression via regulating ubiquitination and degradation of Tara.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194665     DOI: 10.1016/j.bbrc.2008.01.022

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  The role of E3 ubiquitin ligase HECTD3 in cancer and beyond.

Authors:  Qiuyun Jiang; Fubing Li; Zhuo Cheng; Yanjie Kong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

2.  Identification of GABA(C) receptor protein homeostasis network components from three tandem mass spectrometry proteomics approaches.

Authors:  Ya-Juan Wang; Dong-Yun Han; Tracy Tabib; John R Yates; Ting-Wei Mu
Journal:  J Proteome Res       Date:  2013-10-11       Impact factor: 4.466

3.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

4.  An unpredicted aggregation-critical region of the actin-polymerizing protein TRIOBP-1/Tara, determined by elucidation of its domain structure.

Authors:  Nicholas J Bradshaw; Antony S K Yerabham; Rita Marreiros; Tao Zhang; Luitgard Nagel-Steger; Carsten Korth
Journal:  J Biol Chem       Date:  2017-04-24       Impact factor: 5.157

5.  Interaction between syntaxin 8 and HECTd3, a HECT domain ligase.

Authors:  Lisheng Zhang; Liang Kang; William Bond; Nian Zhang
Journal:  Cell Mol Neurobiol       Date:  2008-09-27       Impact factor: 5.046

6.  The HECTD3 E3 ubiquitin ligase suppresses cisplatin-induced apoptosis via stabilizing MALT1.

Authors:  Yi Li; Xi Chen; Zehua Wang; Dong Zhao; Hui Chen; Wenlin Chen; Zhongmei Zhou; Junran Zhang; Jing Zhang; Hongmin Li; Ceshi Chen
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

Review 7.  Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness.

Authors:  Nicholas J Bradshaw; Carsten Korth
Journal:  Mol Psychiatry       Date:  2018-08-08       Impact factor: 15.992

8.  A genomic survey of HECT ubiquitin ligases in eukaryotes reveals independent expansions of the HECT system in several lineages.

Authors:  Xavier Grau-Bové; Arnau Sebé-Pedrós; Iñaki Ruiz-Trillo
Journal:  Genome Biol Evol       Date:  2013       Impact factor: 3.416

9.  The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8.

Authors:  Y Li; Y Kong; Z Zhou; H Chen; Z Wang; Y-C Hsieh; D Zhao; X Zhi; J Huang; J Zhang; H Li; C Chen
Journal:  Cell Death Dis       Date:  2013-11-28       Impact factor: 8.469

10.  Whole exome sequencing identifies TRIOBP pathogenic variants as a cause of post-lingual bilateral moderate-to-severe sensorineural hearing loss.

Authors:  Agnieszka Pollak; Urszula Lechowicz; Victor Abel Murcia Pieńkowski; Piotr Stawiński; Joanna Kosińska; Henryk Skarżyński; Monika Ołdak; Rafał Płoski
Journal:  BMC Med Genet       Date:  2017-12-02       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.